Literature DB >> 28220270

Multiplex assessment of serum cytokine and chemokine levels in idiopathic morphea and vitamin K1-induced morphea.

Lori Ann Cox1,2, Guy F Webster3,4, Sonsoles Piera-Velazquez1,4, Sergio A Jimenez5,6,7.   

Abstract

The levels of 63 cytokines, chemokines, and growth factors were measured in the serum of four patients with idiopathic morphea and of one patient with vitamin K1-induced morphea employing a multiplex assay to identify the role of inflammatory/immunologic events in their pathogenesis. Full-thickness skin biopsies of affected skin were analyzed by histopathology. Luminex assays for 63 cytokines, chemokines, and growth factors were performed in the sera from four patients with idiopathic morphea and in two different samples of serum obtained in two separate occasions from one patient with vitamin K1-induced morphea. The serum values of numerous inflammatory cytokines and growth factors including IL-2, IL-4, IL-6, and IFNβ were markedly increased in the serum of patients with idiopathic morphea, whereas, these values were normal in the serum of the patient with vitamin K1-induced morphea. In contrast, serum eotaxin levels were greater than threefold higher in the patient with vitamin K1-induced morphea compared to patients with idiopathic morphea. The results demonstrated remarkable increases in the levels of numerous cytokines and chemokines in the serum samples of all patients with idiopathic morphea indicative of a prominent role of inflammatory/immunologic events in its pathogenesis. The results also showed statistically significant differences between idiopathic morphea and vitamin K1-induced morphea suggesting that their development involves different pathogenetic mechanisms.

Entities:  

Keywords:  Chemokine levels; Localized scleroderma; Morphea; Serum cytokine

Mesh:

Substances:

Year:  2017        PMID: 28220270     DOI: 10.1007/s10067-017-3580-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Histopathologic differentiation between localized and systemic scleroderma.

Authors:  J E Torres; J L Sánchez
Journal:  Am J Dermatopathol       Date:  1998-06       Impact factor: 1.533

2.  [Scleroderma-like hypodermitis of the buttock due to intramuscular injection of drugs combined with vitamin K 1 ].

Authors:  L Texier; P Gendre; O Gauthier; Y Gauthier; J E Surlévé-Bazeille; D Boineau
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1972

Review 3.  Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.

Authors:  Nicole Fett; Victoria P Werth
Journal:  J Am Acad Dermatol       Date:  2011-02       Impact factor: 11.527

4.  Morphea-like reaction from vitamin K1.

Authors:  A Morell; I Betlloch; A Sevila; J Bañuls; R Botella
Journal:  Int J Dermatol       Date:  1995-03       Impact factor: 2.736

5.  Pseudoscleroderma secondary to phytonadione (vitamin K1) injections.

Authors:  R M Pujol; L Puig; A Moreno; M Pérez; J M de Moragas
Journal:  Cutis       Date:  1989-04

Review 6.  Cytokine profiles in localized scleroderma and relationship to clinical features.

Authors:  Katherine Kurzinski; Kathryn S Torok
Journal:  Cytokine       Date:  2011-05-04       Impact factor: 3.861

7.  "Cowboy's belt with revolver" scleroderma caused by vitamin K1 injections.

Authors:  S Lembo; M Megna; A Balato; N Balato
Journal:  G Ital Dermatol Venereol       Date:  2012-04       Impact factor: 2.011

8.  Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis.

Authors:  Domenica Mangieri; Domenico Corradi; Davide Martorana; Giovanni Malerba; Alessandra Palmisano; Irene Libri; Veronica Bartoli; Maria L Carnevali; Matteo Goldoni; Paolo Govoni; Rossella Alinovi; Carlo Buzio; Augusto Vaglio
Journal:  Nephrol Dial Transplant       Date:  2012-10       Impact factor: 5.992

Review 9.  Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions.

Authors:  Johanna Canady; Sigrid Karrer; Martin Fleck; Anja K Bosserhoff
Journal:  J Dermatol Sci       Date:  2013-04-08       Impact factor: 4.563

10.  Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.

Authors:  Heidi Jacobe; Chul Ahn; Frank C Arnett; John D Reveille
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

View more
  1 in total

Review 1.  Morphea - selected local treatment methods and their effectiveness.

Authors:  Joanna Narbutt; Agnieszka Hołdrowicz; Aleksandra Lesiak
Journal:  Reumatologia       Date:  2017-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.